Skip to main content
Category

Select 2023 Publications

Doxycycline Postexposure Prophylaxis and Bacterial Sexually Transmitted Infections Among Individuals Using HIV Preexposure Prophylaxis

By Publications, Select 2023 Publications

Doxycycline Postexposure Prophylaxis and Bacterial Sexually Transmitted Infections Among Individuals Using HIV Preexposure Prophylaxis

Traeger MW, Leyden W, Volk JE, Silverberg MJ, Horberg MA, Davis TL, Mayer KH, Krakower DS, Young JG, Jenness SM, Marcus JL

This is a study to understand risk for sexually transmitted infections among adults who were members of Kaiser Permanente (2022-2023) and used medical HIV prevention (PrEP). Our goal was to understand the risk of sexually transmitted infections (STIs) for people using PrEP to prevent HIV and DoxyPEP to prevent sexually transmitted infections (STIs). People who took doxycycline (doxyPEP) after being exposed to an STI had lower rates of getting an STI compared to people who did not take doxyPEP. DoxyPEP can help stop transmission of STIs and if it is used more widely.

Click here for the PubMed entry.